Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

A tétel rövid nézete
dc.contributor.authorHirschfield, Gideon M.
dc.contributor.authorShiffman, Mitchell L.
dc.contributor.authorGulamhusein, Aliya
dc.contributor.authorKowdley, Kris V.
dc.contributor.authorVierling, John M.
dc.contributor.authorLevy, Cynthia
dc.contributor.authorKremer, Andreas E.
dc.contributor.authorZigmond, Ehud
dc.contributor.authorAndreone, Pietro
dc.contributor.authorGordon, Stuart C.
dc.contributor.authorBowlus, Christopher L.
dc.contributor.authorLawitz, Eric J.
dc.contributor.authorAspinall, Richard J.
dc.contributor.authorPratt, Daniel S.
dc.contributor.authorRaikhelson, Karina
dc.contributor.authorGonzalez-Huezo, Maria S.
dc.contributor.authorHeneghan, Michael A.
dc.contributor.authorJeong, Sook-Hyang
dc.contributor.authorGuevara, Alma L. Ladrón de
dc.contributor.authorMayo, Marlyn J.
dc.contributor.authorDalekos, George N.
dc.contributor.authorDrenth, Joost P. H.
dc.contributor.authorJanczewska, Ewa
dc.contributor.authorLeggett, Barbara A.
dc.contributor.authorNevens, Frederik
dc.contributor.authorVargas, Victor
dc.contributor.authorZuckerman, Eli
dc.contributor.authorCorpechot, Christophe
dc.contributor.authorFassio, Eduardo
dc.contributor.authorHinrichsen, Holger
dc.contributor.authorInvernizzi, Pietro
dc.contributor.authorTrivedi, Palak J.
dc.contributor.authorForman, Lisa
dc.contributor.authorJones, David E. J.
dc.contributor.authorRyder, Stephen
dc.contributor.authorSwain, Mark G.
dc.contributor.authorSteinberg, Alexandra
dc.contributor.authorBoudes, Pol F.
dc.contributor.authorChoi, Yun-Jung
dc.contributor.authorMcWherter, Charles A.
dc.contributor.authorPapp, Mária
dc.date.accessioned2024-04-24T10:04:19Z
dc.date.available2024-04-24T10:04:19Z
dc.date.issued2023
dc.date.oa2024-05-08
dc.date.pasync2024-05-08T23:06:47Z
dc.date.updated2024-04-24T10:04:19Z
dc.description.correctorkzs
dc.identifier.citationHepatology. -78 : 2 (2023), p. 397-415. -Hepatology. - 0270-9139
dc.identifier.doihttp://dx.doi.org/10.1097/HEP.0000000000000395
dc.identifier.issn0270-9139
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM120677
dc.identifier.scopus85165221969
dc.identifier.urihttps://hdl.handle.net/2437/369218
dc.identifier.urlhttps://journals.lww.com/10.1097/HEP.0000000000000395
dc.identifier.wos001032215200024
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleSeladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
dc.typefolyóiratcikk
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_seladelpar_efficacy_and_safety_at_3_months_in.9.pdf
Méret:
2.08 MB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis